Antioxidant Therapy, N-Acetyl-L-Cysteine, Effects On Pancreatic Beta Cells: Therapeutic Promise Or Potential Harm?
Many people are interested in antioxidants for their potential health benefits, especially for conditions like metabolic disease. One such antioxidant, N-acetyl-L-cysteine (NAC), has been widely used, but its full impact on the specialized cells in the pancreas that produce insulin, called beta cells, is still being understood.
Research shows that when the body is under significant stress from conditions like obesity or type 2 diabetes, where there’s an excess of harmful molecules called “oxidative stress,” NAC can be quite helpful. In these situations, it can protect beta cells from damage, help them continue releasing insulin, and reduce scarring in the pancreas.
However, the picture changes when the body is in a normal, healthy state or simply aging. Our beta cells actually need a certain level of these “harmful” molecules, known as reactive oxygen species (ROS), to function correctly and release insulin. If there’s too much antioxidant, it can throw off this delicate balance, potentially interfering with insulin production and release, a state sometimes referred to as “reductive stress.”
Ultimately, whether this antioxidant is helpful or harmful to beta cells depends on several factors: the body’s current antioxidant-oxidant balance, the overall metabolic environment, and the amount of the supplement being taken. This highlights the importance of carefully considering antioxidant use in people, suggesting that a personalized approach is best rather than widespread, long-term use without proper evaluation.
Source: link to paper